x

Posted 27 September, 2023

Krispy Kreme, Inc. appointed Mr. Joshua Charlesworth as new CEO

Nasdaq:DNUT appointed new Chief Executive Officer Mr. Joshua Charlesworth in a 8-K filed on 27 September, 2023.


  Appointment of Mr. Joshua Charlesworth to President and CEO  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Krispy Kreme, Inc.
Leisure/Arts/Hospitality • Restaurants
Krispy Kreme, Inc. produces and distributes doughnuts. It offers yeast-raised doughnuts, pies, coffees and espresso drinks, chillers and iced beverages. It operates through the following segments: U.S. and Canada, International, and Market Development. The U.S. and Canada segment includes all Krispy Kreme’s company-owned operations in the U.S. and Canada, Insomnia-branded retail shops and consumer packaged goods operations. The International segment consists of all Krispy Kreme's company-owned operations in the United Kingdom, Ireland, Australia, New Zealand, and Mexico. The Market Development segment handles the franchise operations across the globe, as well as Krispy Kreme company-owned shops in Japan. The firm sells its products through mass merchant, grocery and convenience stores. The company was founded in 1937 and is headquartered in Charlotte, NC.
Market Cap
$2.12B
View Company Details
Relevant filing section
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of Mr. Joshua Charlesworth to President and CEO

On September 22, 2023, the Board of Directors (the "Board") of Krispy Kreme, Inc. (the "Company") appointed Mr. Joshua Charlesworth to the role of President and Chief Executive Officer of the Company, effective as of January 1, 2024 (the "Appointment Date"), at which time he will resign from his current role of Global President and Chief Operating Officer of the Company. 

Following the Appointment Date, Mr. Charlesworth (i) will receive an annual base salary of $1,000,000, (ii) will be eligible to participate in the Company's annual bonus program with a target bonus opportunity equal to 100% of his base salary and a maximum bonus opportunity equal to 200% of his base salary, and (iii) will receive annual grants of restricted stock units under the Company's 2021 Omnibus Incentive Plan (the "LTI Plan") with a grant date fair value of $1,000,000 (the "Annual Award"), subject to the terms of the LTI Plan and the applicable award agreement. For 2024, half of the Annual Award will be subject to service-based vesting conditions vesting 60% on the third anniversary of the grant date, (B) 20% on the fourth anniversary of the grant date and (C) 20% on the fifth anniversary of the grant date. The remaining half of the Annual Award for 2024 will be subject to performance vesting conditions vesting on the last day of the Company's 2026 fiscal year, subject to the achievement of applicable performance goals.

In addition, on November 1, 2023, Mr. Charlesworth will receive a grant of 492,142 restricted stock units under the LTI Plan, representing a matching award on Company shares that he will own as of such date. This matching award will vest on the fifth anniversary of the grant date, subject to the terms of the LTI Plan and the applicable award agreement. Further, subject to the approval of the Board of Directors of Krispy Kreme Doughnut Corporation ("KKDC"), Mr. Charlesworth will be granted an award of 3,925 restricted equity units ("REUs") under the Insomnia Cookies Holdings, LLC Executive Ownership Plan (the "Insomnia EOP"), which will vest (i) 60% on the third anniversary of the grant date, (ii) 20% on the fourth anniversary of the grant date, and (iii) 20% on the fifth anniversary of the grant date, subject to the terms of the Insomnia EOP and the applicable award agreement.

If Mr. Charlesworth's employment is terminated without cause by the Company or if Mr. Charlesworth terminates his employment for good reason, he will be entitled to, subject to executing a release of claims, (i) continued payment of his base salary for a period of twenty-four months and (ii) a lump-sum payment equal to the approximate value of eighteen months of subsidized COBRA coverage premiums. 

Mr. Charlesworth is not a party to any transaction with the Company that would be reportable under Item 404(a) of Regulation S-K under the Securities Act of 1933. Mr. Charlesworth is not a party to any material plan, contract, or arrangement in connection with his employment.

Transition of Mr. Michael Tattersfield to Non-Executive Roles

On September 22, 2023, Michael Tattersfield, the Company's President and Chief Executive Officer, notified the Board that he will step down as the Company's President and Chief Executive Officer, effective December 31, 2023 (the "Transition Date"), and that following the Transition Date, Mr. Tattersfield will continue to provide services to the Company as (i) a non-executive member of the Board (the "Director Services") and (ii) a Company ambassador and senior advisor to the successor President and Chief Executive Officer, Mr. Charlesworth (the "Advisor Services"). In addition, both prior to and following the Transition Date, Mr. Tattersfield will continue to provide strategic support to Insomnia Cookies Holdings, LLC.

While Mr. Tattersfield provides the Director Services, Mr. Tattersfield will be entitled to receive compensation on the same basis as other non-employee directors of the Board. While Mr. Tattersfield provides the Advisor Services, Mr. Tattersfield will be entitled to receive a consulting fee of $50,000 per month. 

Outstanding and unvested equity awards of the Company held by Mr. Tattersfield as of the Separation Date (the "Continuing Awards") will continue to vest while Mr. Tattersfield provides the Director Services or the Advisor Services. If the Director Services and the Advisor Services are both terminated prior to June 30, 2026, for any reason other than due to cause or due to Mr. Tattersfield's resignation for any reason, then the vesting of any of his then-outstanding unvested Continuing Awards that would have vested on or prior to June 30, 2026 will accelerate (provided that performance awards will continue to be subject to the achievement of applicable performance criteria). 

In addition, subject to the approval of the Board of Directors of KKDC, as soon as practicable following September 22, 2023, Mr. Tattersfield will be granted an award of 15,699 REUs under the Insomnia EOP, which will vest (i) 60% on the third anniversary of the grant date, (ii) 20% on the fourth anniversary of the grant date, and (iii) 20% on the fifth anniversary of the grant date, subject to the terms of the Insomnia EOP and the applicable award agreement.